Zhou Xue Li - Net Worth and Insider Trading
Zhou Xue Li Net Worth
The estimated net worth of Zhou Xue Li is at least $9 Million dollars as of 2024-11-07. Zhou Xue Li is the Director of Guangdong Zhongsheng Pharmaceutical Co Ltd and owns about 675,000 shares of Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) stock worth over $9 Million. Details can be seen in Zhou Xue Li's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Zhou Xue Li has not made any transactions after 2019-03-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Zhou Xue Li
Zhou Xue Li Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Zhou Xue Li owns 1 companies in total, including Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) .
Click here to see the complete history of Zhou Xue Li’s form 4 insider trades.
Insider Ownership Summary of Zhou Xue Li
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SZSE:002317 | Guangdong Zhongsheng Pharmaceutical Co Ltd | 2019-03-05 | Director |
Zhou Xue Li Latest Holdings Summary
Zhou Xue Li currently owns a total of 1 stock. Zhou Xue Li owns 675,000 shares of Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) as of March 5, 2019, with a value of $9 Million.
Latest Holdings of Zhou Xue Li
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SZSE:002317 | Guangdong Zhongsheng Pharmaceutical Co Ltd | 2019-03-05 | 675,000 | 13.46 | 9,085,500 |
Holding Weightings of Zhou Xue Li
Zhou Xue Li Form 4 Trading Tracker
According to the SEC Form 4 filings, Zhou Xue Li has made a total of 0 transactions in Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) over the past 5 years. The most-recent trade in Guangdong Zhongsheng Pharmaceutical Co Ltd is the sale of 225,000 shares on March 5, 2019, which brought Zhou Xue Li around $2 Million.
Insider Trading History of Zhou Xue Li
- 1
Zhou Xue Li Trading Performance
Zhou Xue Li Ownership Network
Ownership Network List of Zhou Xue Li
Ownership Network Relation of Zhou Xue Li
Zhou Xue Li Owned Company Details
What does Guangdong Zhongsheng Pharmaceutical Co Ltd do?
Who are the key executives at Guangdong Zhongsheng Pharmaceutical Co Ltd?
Zhou Xue Li is the Director of Guangdong Zhongsheng Pharmaceutical Co Ltd. Other key executives at Guangdong Zhongsheng Pharmaceutical Co Ltd include Directors & executives Chen Yong Hong , Executives Zhao Xi Ping , and Secretary & Director Zhang Yu Chong .
Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) Insider Trades Summary
Over the past 18 months, Zhou Xue Li made no insider transaction in Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317). Other recent insider transactions involving Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) include a net purchase of 202,400 shares made by Chen Yong Hong ,
In summary, during the past 3 months, insiders sold 0 shares of Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) were sold and 202,400 shares were bought by its insiders, resulting in a net purchase of 202,400 shares.
Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317)'s detailed insider trading history can be found in Insider Trading Tracker table.
Guangdong Zhongsheng Pharmaceutical Co Ltd Insider Transactions
Zhou Xue Li Mailing Address
Above is the net worth, insider trading, and ownership report for Zhou Xue Li. Currently GuruFocus does not have mailing address information for Zhou Xue Li.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
